» Articles » PMID: 18157829

Progranulin Locus Deletion in Frontotemporal Dementia

Overview
Journal Hum Mutat
Specialty Genetics
Date 2007 Dec 25
PMID 18157829
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

Ubiquitin-positive, tau-negative, frontotemporal dementia (FTD) is caused by null mutations in progranulin (PGRN; HUGO gene symbol GRN), suggesting a haploinsufficiency mechanism. Since whole gene deletions also lead to the loss of a functional allele, we performed systematic quantitative analyses of PGRN in a series of 103 Belgian FTD patients. We identified in one patient (1%) a genomic deletion that was absent in 267 control individuals. The deleted segment was between 54 and 69 kb in length and comprised PGRN and two centromeric neighboring genes RPIP8 (HUGO gene symbol RUNDC3A) and SLC25A39. The patient presented clinically with typical FTD without additional symptoms, consistent with haploinsufficiency of PGRN being the only gene contributing to the disease phenotype. This study demonstrates that reduced PGRN in absence of mutant protein is sufficient to cause neurodegeneration and that previously reported PGRN mutation frequencies are underestimated.

Citing Articles

Two novel variants in GRN: the relevance of CNV analysis and genetic screening in FTLD patients with a negative family history.

De Houwer J, Dopper E, Rajicic A, van Buuren R, Arcaro M, Galimberti D J Neurol. 2024; 272(1):64.

PMID: 39680222 PMC: 11649753. DOI: 10.1007/s00415-024-12758-7.


Benzoxazole-derivatives enhance progranulin expression and reverse the aberrant lysosomal proteome caused by GRN haploinsufficiency.

Tesla R, Guhl C, Werthmann G, Dixon D, Cenik B, Addepalli Y Nat Commun. 2024; 15(1):6125.

PMID: 39033178 PMC: 11271458. DOI: 10.1038/s41467-024-50076-8.


CNS-wide repopulation by hematopoietic-derived microglia-like cells corrects progranulin deficiency in mice.

Colella P, Sayana R, Suarez-Nieto M, Sarno J, Nyame K, Xiong J Nat Commun. 2024; 15(1):5654.

PMID: 38969669 PMC: 11226701. DOI: 10.1038/s41467-024-49908-4.


Preclinical Interventions in Mouse Models of Frontotemporal Dementia Due to Progranulin Mutations.

Kashyap S, Boyle N, Roberson E Neurotherapeutics. 2023; 20(1):140-153.

PMID: 36781744 PMC: 10119358. DOI: 10.1007/s13311-023-01348-6.


AZP2006, a new promising treatment for Alzheimer's and related diseases.

Callizot N, Estrella C, Burlet S, Henriques A, Brantis C, Barrier M Sci Rep. 2021; 11(1):16806.

PMID: 34413330 PMC: 8376949. DOI: 10.1038/s41598-021-94708-1.